首页|儿科用药决策支持平台的构建及实践成效分析

儿科用药决策支持平台的构建及实践成效分析

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
目的 构建基于处方前置审核系统的儿科用药决策支持平台,对其在儿科患者中的实践成效进行分析.方法 挖掘我院处方大数据,建立用药知识库,搭建儿科用药决策支持平台;收集我院2021 年和2022 年处方前置审核系统的儿科门诊处方资料,评价平台实施成效.结果 构建了儿科用药决策支持平台;平台使用后我院儿科门诊处方系统预审张次增多,预审问题处方张次及刚性拦截处方张次显著减少;处方合格率从2021 年的77.43%升高至2022 年的86.40%,不合理处方减少.结论 儿科用药决策支持平台的构建及实施,显著提高了儿科处方质量及合理用药水平.
Construction of Pediatric Medication Decision Support Platform and Analy-sis of Practical Results
OBJECTIVE A prescription pre-review system was utilized to develop a pediatric medication deci-sion support platform,which was subsequently evaluated for its efficacy in pediatric patients.METHODS The pres-ent study involves the extraction of extensive prescription data from our hospital,with the aim of establishing a com-prehensive drug knowledge base and developing a pediatric drug decision support platform.To assess the effectiveness of this platform,prescription data from the pediatric outpatient department were collected for the years 2021 and 2022,specifically focusing on the evaluation of its implementation.RESULTS A pediatric medication decision sup-port platform was developed,resulting in an increase in the number of pre-examination prescriptions within our hospi-tal's pediatric outpatient prescription system.Additionally,there was a notable decrease in the number of pre-exami-nation problem prescriptions and rigid interception prescriptions.The qualified rate of prescriptions also experienced a positive shift,rising from 77.43%in 2021 to 86.40%in 2022,while the occurrence of irrational prescriptions de-creased.CONCLUSION The construction and implementation of pediatric medication decision support platform significantly improved the quality of pediatric prescription and rational drug use.

PediatricsRational drug useDecision support platformPractical effect analysis

杨坤、邢相宜、马丙锁、张海珠、张良明、袁晓燕、余婷、晏子俊

展开 >

大理大学药学院,云南大理 671000

攀枝花市中心医院药学部,四川攀枝花 617067

儿科 合理用药 决策支持平台 实践成效分析

云南省科技厅地方高校联合专项面上项目云南省科技厅地方高校联合专项面上项目四川省中医药局科研项目四川省预防医学会项目四川省医院协会青年药师科研专项

202001BA070001-0412019FE001-302023MS057川预学-静配-2020-00522009

2024

海峡药学
中国药学会福建分会

海峡药学

影响因子：0.643
ISSN：1006-3765
年,卷(期)：2024.36(2)
  • 17